San Francisco Bay Area Biometrics Consulting
Request a Consultation Pharma Recruiting  Contact Us Iphone  925-320-7600 
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7
San Francisco Bay Area Biometrics Consulting
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZlcnNpb249IjEuMCIgd2lkdGg9IjkwMCIgaGVpZ2h0PSIzMDAiID48L3N2Zz4=

Video: Let's Make Oncology Studies Easy for Programmers and Statisticians

B2ap3 Large Lets Make Oncology Studies Easy For Programmers And Statisticians
The World Health Organization (WHO) predicts that new cancer cases will increase from 14 million in 2012 to 22 million in 2030 and cancer deaths will increase from 8.2 million to 13 million annually.   In addition, oncology revenue from the pharmaceutical industry is expected to increase to $150 billion by 2020 from $107 billion in 2015. Almost all pharmaceutical companies are invested in bringing innovative oncology drugs to market, so the demand for oncology-experienced programmers and statisticians has also increased.   
 
Compared to other therapeutic studies however, oncology studies are complex and difficult for programmers and statisticians. In particular, oncology studies require a specific way for data collection and analysis. In this webinar, we will take a look at how oncology studies differ from other therapeutic studies, and how oncology-specific data collections and analysis must be conducted.


 Through this webinar, programmers and statisticians will learn the following:

  • Three Oncology Sub-types - Solid Tumor, Lymphoma and Leukemia
  • Response Criteria Guideline - RECIST for Solid tumor, Cheson for Lymphoma and IWCLL for Chronic Lymphocytic Leukemia
  • Data Collections Based on Response Criteria
  • CDISC SDTM Tumor Domains - TR, TU, RS
  • Tumor Response - Complete Response, Partial Response, Stable Disease and Progression Disease
  • CDISC Time to Event ADaM Datasets
  • Events and Censoring
  • Oncology-specific Analysis - Overall Survival, Progression Free Survival, Overall Response Rate  

 

Click to View Video Here

 

UC Berkeley Statistics Annual Research Symposium (...
Symposium: Dose Selection for Cancer Treatment Dru...

Related Posts

Ready to Get Started?

Schedule a No Obligation Consultation with a Clindata Insight Representative Today

Kevin Lee
17 May 2016
The Food and Drug Administration (FDA) recently published version 3.0 of the Technical Conformance ...
Admin
14 February 2017
Kevin Lee, Director of Data Science at Clindata, has been invited to speak at the next New Jersey CD...
Admin
26 August 2016
  On August 5, 2016, FDA released a new version of the Study Data Technical Conformance Guide v...

Copyright © 2016   Clindata Insight Inc.   All Rights Reserved

Clindata Insight Inc, provides equal employment opportunities (EEO) to all applicants for employment without regard to race, color, religion, sex, national orgin, age, disability or genetics.  In addition to federal law requirements Clindata Insight complies with applicable state and local laws governing non discrimination in employment.

        (925) 320-7600